Rallybio Corporation
NASDAQ:RLYB · NASDAQ Capital Market
+$0.01 today
Vol 0.02M · Avg 0.25M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+538.80%
Period High
$16.87
Period Low
$2.50
Latest
$15.97
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Q32 Bio Inc.
NASDAQ:QTTB
$156.64M
Boundless Bio, Inc.
BOLD
$31.90M
iBio, Inc.
IBIO
$25.97M
Klotho Neurosciences, Inc.
KLTO
$20.08M
Exicure, Inc.
XCUR
$15.81M
TAO Synergies Inc.
TAOX
$12.09M
Cadrenal Therapeutics, Inc. Common Stock
CVKD
$9.39M
Sonnet BioTherapeutics Holdings, Inc.
SONN
$8.43M
Intensity Therapeutics, Inc.
INTS
$7.17M
Iterum Therapeutics plc
ITRM
$1.60M
What is the latest RLYB filing?
The latest filing shown is SC 13G dated Jun 5, 2026.
How many recent filings does RLYB have?
Intrinsic Alpha currently shows 20 recent filings for RLYB.
Explore More
Continue the stock analysis
Jump to another research area for this company.